N-hydroxyamide derivatives possessing antibacterial activity

Details for Australian Patent Application No. 2003267991 (hide)

Owner Vicuron Pharmaceuticals, Inc.

Inventors Patel, Dinesh V.; Gao, Hongwu; Raju, Bore G.; Trias, Joaquim; Odowd, Hardwin

Agent FB Rice

Pub. Number AU-B-2003267991

PCT Number PCT/US03/21838

PCT Pub. Number WO2004/007444

Priority 60/394,862 11.07.02 US

Filing date 11 July 2003

Wipo publication date 2 February 2004

Acceptance publication date 8 October 2009

International Classifications

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/22 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

8 January 2004 Complete Application Filed

  Priority application(s): 60/394,862 11.07.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-B-2003267991

8 October 2009 Application Accepted

  Published as AU-B-2003267991

4 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003267992-MYCOPLASMA GALLISEPTICUM FORMULATION

2003267990-PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (PACAP) RECEPTOR (VPAC2) AGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE